The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Result of General Meeting

29 Aug 2019 14:06

RNS Number : 6007K
Feedback PLC
29 August 2019
 

Feedback plc

Result of General Meeting

Cambridge, 29 August 2019: Feedback plc (AIM: FDBK, "Feedback" or the "Company") announces that at the general meeting of the Company held earlier today, all resolutions were duly passed, including resolutions 1 and 2 pertaining to the Company's placing and subscription. 

The proxy voting results of the resolutions are included below:

Votes For*

% of votes cast

Votes Against

% of votes cast

Votes Withheld

% of votes cast

Total votes cast

 Ordinary Resolution

1

153,457,280

99.33%

1,030,175

0.67%

-

-

154,487,455

Special Resolution

2

153,422,190

99.31%

1,030,129

0.67%

35,136

0.02%

154,487,455

 Ordinary Resolution

3

153,407,106

99.30%

1,054,525

0.68%

25,824

0.02%

154,487,455

Special Resolution

4

153,411,906

99.30%

1,049,725

0.68%

25,824

0.02%

154,487,455

*"Votes For" include votes giving the Chairman discretion.

Total Voting Rights

Further to the announcement on 12 August 2019, Admission of the New Ordinary Shares is expected to take place at 8:00 a.m. on 30 August 2019.

On Admission, the issued share capital of the Company will consist of 539,949,917 Ordinary Shares with one voting right each. The Company does not hold any ordinary shares in treasury. Therefore, the total number of ordinary shares and voting rights in the Company will be 539,949,917. With effect from Admission, this figure may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Capitalised terms used but not defined in this announcement shall have the meanings given to such terms in the section headed 'Definitions' in the Company's announcement of 12 August 2019.

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO 

 

+44 (0)1954 718072

IR@fbk.com

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai 

 

+44 (0)20 3328 5656

Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey 

 

+44 (0)20 7469 0936

Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

 

Instinctif Partners

Rozi Morris / Phillip Marriage

+44 20 3815 8880

 

 

+44 (0)20 7457 2020

feedbackplc@instinctif.com

 

Notes to editors

About Feedback plc

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD®, the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS). The Company has recently announced the launch of its new messaging and image transfer product Bleepa™.For more information, see www.fbk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMPGUWURUPBGWB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.